STE
STERIS plc
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
-15/100
Last price
208.65
▼ 2.42 (1.15%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
211.07
Prev close
211.07
Day high
213.17
Day low
207.97
Volume
909.38K
Market cap
$20.34B
P/E (TTM)
25.79
52W range
195.14 – 269.44
Day trading desk
Gap from prior close
-0.00%
Prior close 211.07
VWAP
209.21
-0.27% from price
Relative volume
2.07×
Unusually busy
Session range
2.50%
207.97 – 213.17
Position in range
13%
Near session low
ATR (14D)
3.69
1.77% of price
Prior day high
213.05
PDH
Prior day low
207.46
PDL
Bid / ask spread
—
Quote not published
Session volume
1.44M
Avg 692.78K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.95%
-2.9%
1M
-7.10%
-8.3%
3M
-0.40%
-4.9%
6M
-4.82%
-23.0%
YTD
-17.70%
-31.9%
1Y
-13.96%
-30.4%
3Y
-4.91%
-87.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on STE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+47.83K
Net buying
Buy transactions
12
59.22K shares
Sell transactions
4
11.39K shares
Net transactions
+16
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
297.38K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | SOHI MOHSEN M Director |
SELL | 4.06K | $956.79K | Direct |
| Aug 12, 26 | SOHI MOHSEN M Director |
CONVERSION | 4.06K | $349.92K | Direct |
| Jul 1, 26 | SOHI MOHSEN M Director |
CONVERSION | 3.78K | $269.96K | Direct |
| Jun 15, 26 | ZANGERLE JOHN ADAM General Counsel |
SELL | 1.42K | $296.97K | Direct |
| Jun 5, 26 | CARESTIO DANIEL A Chief Executive Officer |
SELL | 4.43K | $946.80K | Direct |
| Jun 2, 26 | BREEDEN RICHARD C. Director |
SELL | 1.48K | $310.28K | Direct |
| Jun 2, 26 | BREEDEN RICHARD C. Director |
CONVERSION | 3.78K | $269.96K | Direct |
| Jun 2, 26 | MAJORS CARY L Officer |
STOCK | 4.75K | $0 | Direct |
| Jun 2, 26 | FRASER MARY CLARE Officer |
STOCK | 3.01K | $0 | Direct |
| Jun 2, 26 | MADSEN JULIA Officer |
STOCK | 2.32K | $0 | Direct |
| Jun 2, 26 | KOHLER KENNETH E Officer |
STOCK | 2.20K | $0 | Direct |
| Jun 2, 26 | MCGOWAN LINDSEY Officer |
STOCK | 1.16K | $0 | Direct |
| Jun 2, 26 | ZANGERLE JOHN ADAM General Counsel |
STOCK | 4.36K | $0 | Direct |
| Jun 2, 26 | CARESTIO DANIEL A Chief Executive Officer |
STOCK | 23.74K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BREEDEN RICHARD C. |
Director | 66.21K | Sale |
BURTON KAREN L |
Chief Financial Officer | 13.46K | Stock Award(Grant) |
CARESTIO DANIEL A |
Chief Executive Officer | 63.65K | Sale |
FRASER MARY CLARE |
Officer | 14.63K | Stock Award(Grant) |
KOHLER KENNETH E |
Officer | 11.67K | Stock Award(Grant) |
MADSEN JULIA |
Officer | 12.69K | Stock Award(Grant) |
MAJORS CARY L |
Officer | 17.41K | Stock Award(Grant) |
SOHI MOHSEN M |
Director | 24.30K | Sale |
TOKICH MICHAEL JOSEPH |
Chief Financial Officer | 47.82K | Stock Award(Grant) |
ZANGERLE JOHN ADAM |
General Counsel | 35.26K | Sale |
Fundamentals
Market cap$20.34B
Enterprise value$21.92B
Revenue (TTM)$6.04B
Gross profit$2.68B
EBITDA$1.64B
Net income$805.00M
EPS (TTM)$8.09
Free cash flow$798.86M
Total cash$482.30M
Total debt$2.04B
Book value / share$73.92
Shares outstanding97.50M
Float97.08M
Short % of float2.87%
Dividend yield1.22%
Beta (5Y)0.93
Valuation & profitability ratios
Trailing P/E25.79
Forward P/E17.04
PEG ratio1.76
Price / sales—
Price / book2.82
EV / revenue3.63
EV / EBITDA13.36
Gross margin44.42%
Operating margin19.15%
Profit margin13.33%
Return on equity11.39%
Return on assets6.80%
Debt / equity28.31
Current ratio1.91
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.94B | $5.46B | $5.14B | $4.54B | +8.7% |
| Operating revenue | $5.94B | $5.46B | $5.14B | $4.54B | +8.7% |
| Cost of revenue | $3.31B | $3.06B | $2.92B | $2.56B | +8.3% |
| Gross profit | $2.63B | $2.40B | $2.22B | $1.98B | +9.3% |
| Research & development | $112.90M | $107.60M | $103.70M | $98.48M | +4.9% |
| Selling, general & admin | $1.41B | $1.33B | $1.25B | $1.09B | +5.5% |
| Total operating expense | $1.52B | $1.44B | $1.36B | $1.19B | +5.5% |
| Operating income | $1.11B | $960.90M | $862.20M | $791.59M | +15.1% |
| Net interest income | -$50.90M | -$77.90M | -$133.40M | -$110.83M | +34.7% |
| Pre-tax income | $1.05B | $796.20M | $702.80M | $680.27M | +31.5% |
| Tax provision | $262.20M | $184.70M | $149.50M | $124.07M | +42.0% |
| Net income | $782.30M | $614.70M | $378.30M | $107.03M | +27.3% |
| Net income to common | $782.30M | $614.60M | $378.20M | $107.03M | +27.3% |
| Basic EPS | 7.97 | 6.24 | 3.83 | 1.07 | +27.7% |
| Diluted EPS | 7.93 | 6.20 | 3.81 | 1.07 | +27.9% |
| EBIT | $1.11B | $882.50M | $847.20M | $791.10M | +25.6% |
| EBITDA | $1.59B | $1.36B | $1.41B | $1.34B | +17.4% |
| Basic shares | 98.20M | 98.58M | 98.79M | 99.71M | -0.4% |
| Diluted shares | 98.70M | 99.07M | 99.36M | 100.25M | -0.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $439.60M | $171.70M | $207.02M | $208.36M | +156.0% |
| Cash & short-term investments | $439.60M | $171.70M | $207.02M | $208.36M | +156.0% |
| Accounts receivable | $1.09B | $1.04B | $1.01B | $864.99M | +4.7% |
| Inventory | $631.80M | $581.30M | $674.53M | $604.41M | +8.7% |
| Total current assets | $2.39B | $2.00B | $2.87B | $2.01B | +19.7% |
| Property, plant & equipment | $2.32B | $2.11B | $1.94B | $1.80B | +9.6% |
| Goodwill & intangibles | $5.81B | $5.95B | $6.19B | $5.96B | -2.3% |
| Total assets | $10.74B | $10.15B | $11.06B | $10.82B | +5.8% |
| Total current liabilities | $1.15B | $1.02B | $931.13M | $861.84M | +12.0% |
| Current debt | $118.90M | $125.00M | $85.94M | $60.00M | -4.9% |
| Long-term debt | $1.81B | $1.92B | $3.12B | $3.02B | -5.5% |
| Total debt | $2.09B | $2.20B | $3.38B | $3.25B | -5.2% |
| Total liabilities | $3.54B | $3.53B | $4.75B | $4.73B | +0.3% |
| Retained earnings | $3.02B | $2.48B | $2.09B | $1.91B | +21.8% |
| Shareholder equity | $7.18B | $6.60B | $6.30B | $6.08B | +8.8% |
| Working capital | $1.25B | $978.60M | $1.94B | $1.15B | +27.7% |
| Net tangible assets | $1.37B | $653.40M | $112.17M | $121.28M | +109.5% |
| Shares issued | 97.80M | 98.30M | 98.88M | 98.63M | -0.5% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $785.10M | $616.10M | $380.10M | $105.81M | +27.4% |
| Stock-based compensation | $61.70M | $57.40M | $56.50M | $38.95M | +7.5% |
| Change in working capital | $27.10M | $66.50M | -$146.20M | -$250.02M | -59.2% |
| Operating cash flow | $1.34B | $1.15B | $973.30M | $756.95M | +16.8% |
| Capital expenditure | -$369.00M | -$370.10M | -$360.30M | -$361.97M | +0.3% |
| Investing cash flow | -$512.50M | $388.80M | -$887.40M | -$383.33M | -231.8% |
| Share buybacks | -$235.50M | -$211.30M | -$11.80M | -$308.56M | -11.5% |
| Dividends paid | -$241.80M | -$219.90M | -$200.60M | -$183.50M | -10.0% |
| Financing cash flow | -$568.20M | -$1.57B | -$85.20M | -$498.72M | +63.9% |
| Free cash flow | $972.40M | $778.00M | $613.00M | $394.98M | +25.0% |
| End cash position | $439.60M | $171.70M | $207.00M | $208.36M | +156.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | -6.0% |
| Operating revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | -6.0% |
| Cost of revenue | $808.60M | $891.20M | $840.70M | $814.40M | $763.10M | -9.3% |
| Gross profit | $684.20M | $697.10M | $655.50M | $645.90M | $628.00M | -1.9% |
| Research & development | $28.60M | $28.80M | $29.50M | $28.20M | $26.40M | -0.7% |
| Selling, general & admin | $369.70M | $351.80M | $352.30M | $349.70M | $353.80M | +5.1% |
| Total operating expense | $398.30M | $380.60M | $381.80M | $377.90M | $380.20M | +4.7% |
| Operating income | $285.90M | $316.50M | $273.70M | $268.00M | $247.80M | -9.7% |
| Net interest income | -$12.70M | -$12.30M | -$12.00M | -$12.50M | -$14.10M | -3.3% |
| Pre-tax income | $273.50M | $304.50M | $257.80M | $253.10M | $231.90M | -10.2% |
| Tax provision | $72.50M | $84.20M | $63.50M | $60.60M | $53.90M | -13.9% |
| Net income | $200.10M | $220.20M | $192.80M | $191.90M | $177.40M | -9.1% |
| Net income to common | $200.10M | $220.20M | $192.90M | $191.90M | $177.40M | -9.1% |
| Basic EPS | 2.05 | 2.25 | 1.96 | 1.95 | 1.79 | -8.9% |
| Diluted EPS | 2.04 | 2.24 | 1.96 | 1.94 | 1.79 | -8.9% |
| EBIT | $289.30M | $319.60M | $272.70M | $268.00M | $247.80M | -9.5% |
| EBITDA | $413.10M | $443.00M | $394.70M | $389.70M | $367.20M | -6.7% |
| Basic shares | 97.60M | 98.00M | 98.20M | 98.40M | 98.40M | -0.4% |
| Diluted shares | 97.90M | 98.40M | 98.60M | 98.80M | 98.80M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $482.30M | $439.60M | $423.70M | $319.20M | $279.70M | — | +9.7% |
| Cash & short-term investments | $482.30M | $439.60M | $423.70M | $319.20M | $279.70M | — | +9.7% |
| Accounts receivable | $1.01B | $1.09B | $990.60M | $947.30M | $947.10M | — | -7.3% |
| Inventory | $712.10M | $631.80M | $673.50M | $658.50M | $641.20M | — | +12.7% |
| Total current assets | $2.45B | $2.39B | $2.29B | $2.11B | $2.06B | — | +2.1% |
| Property, plant & equipment | $2.32B | $2.32B | $2.29B | $2.25B | $2.22B | — | +0.3% |
| Goodwill & intangibles | $5.75B | $5.81B | $5.92B | $5.96B | $6.04B | — | -1.1% |
| Total assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | — | -0.0% |
| Total current liabilities | $1.28B | $1.15B | $922.30M | $888.90M | $926.60M | — | +12.1% |
| Current debt | $243.40M | $118.90M | — | — | — | $125.00M | +104.7% |
| Long-term debt | $1.65B | $1.81B | $1.90B | $1.90B | $1.90B | — | -9.0% |
| Total debt | $2.04B | $2.09B | $2.05B | $2.06B | $2.07B | — | -2.0% |
| Total liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | — | -0.7% |
| Retained earnings | $3.15B | $3.02B | $2.86B | $2.73B | $2.60B | — | +4.6% |
| Shareholder equity | $7.21B | $7.18B | $7.15B | $7.01B | $6.96B | — | +0.3% |
| Working capital | $1.16B | $1.25B | $1.36B | $1.22B | $1.13B | — | -7.0% |
| Net tangible assets | $1.45B | $1.37B | $1.23B | $1.04B | $916.70M | — | +6.2% |
| Shares issued | 97.46M | 97.80M | 98.15M | 98.10M | 98.50M | — | -0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $201.00M | $220.30M | $194.40M | $192.40M | $178.00M | -8.8% |
| Stock-based compensation | $12.80M | $12.90M | $15.70M | $21.20M | $11.90M | -0.8% |
| Change in working capital | $17.80M | $13.50M | -$36.00M | -$46.60M | $96.20M | +31.9% |
| Operating cash flow | $367.10M | $335.40M | $298.20M | $287.80M | $420.00M | +9.5% |
| Capital expenditure | -$87.50M | -$90.20M | -$98.70M | -$86.50M | -$93.60M | +3.0% |
| Investing cash flow | -$108.50M | -$217.20M | -$98.50M | -$88.30M | -$108.50M | +50.0% |
| Share buybacks | -$115.50M | -$74.30M | -$50.10M | -$100.50M | -$10.60M | -55.5% |
| Dividends paid | -$61.40M | -$61.80M | -$61.90M | -$61.90M | -$56.20M | +0.6% |
| Financing cash flow | -$213.50M | -$97.90M | -$98.00M | -$159.20M | -$213.10M | -118.1% |
| Free cash flow | $279.60M | $245.20M | $199.50M | $201.30M | $326.40M | +14.0% |
| End cash position | $482.30M | $439.60M | $423.70M | $319.20M | $279.70M | +9.7% |
Options analytics
Put / call volume
0.14
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
185.00
-11.3% from spot
ATM implied vol
0.8%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
28
Contracts, this expiry
Put volume
4
Contracts, this expiry
Heaviest call OI
200.00
0 contracts
Heaviest put OI
185.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.49 | 2.59 | +3.9% |
| Mar 2026 | 2.85 | 2.83 | -0.6% |
| Dec 2025 | 2.53 | 2.53 | -0.1% |
| Sep 2025 | 2.35 | 2.47 | +5.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.68 | 8 | $1.56B | +7.1% |
| Next quarter | 2.81 | 8 | $1.61B | +7.6% |
| Current year | 11.17 | 9 | $6.37B | +7.4% |
| Next year | 12.25 | 9 | $6.78B | +6.4% |
Analyst targets & ownership
Mean target$263.13
High target$280.00
Low target$232.00
Implied upside26.11%
Analyst count8
ConsensusBUY
Strong buy / Buy3 / 4
Hold2
Sell / Strong sell0 / 0
Held by insiders0.31%
Held by institutions100.74%
Institutions holding1.22K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
209.69
-0.50% from price
SMA 20
209.90
-0.59% from price
SMA 50
223.73
-6.74% from price
SMA 100
217.85
-4.22% from price
SMA 200
227.75
-8.39% from price
EMA 12
210.24
-0.75% from price
EMA 26
213.93
-2.47% from price
EMA 50
217.37
-4.01% from price
RSI (14)
38.3
Neutral
MACD (12,26,9)
-3.70
Hist 0.66
ATR (14)
3.69
1.77% of price
Realised vol 30D
15.6%
Annualised
Bollinger upper
214.24
20, 2σ
Bollinger lower
205.55
20, 2σ
50 / 200 cross
Death
223.73 vs 227.75
Trend bias
Below 200
-8.39%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.42
Less volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
15.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-25.8%
Peak to trough
Max drawdown 5Y
-36.5%
Peak to trough
ATR 14
3.69
1.77% of price
Beta (reported)
0.93
5Y monthly, from filing
Short interest
Shares short
2.79M
Prior 2.32M
Change vs prior
+20.4%
Shorts adding
% of float
2.87%
Normal
% of shares out
2.86%
Against total outstanding
Days to cover
4.6
Liquid
Float
97.08M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 28, 26 | UBS | INITIATED | — | Buy |
| May 13, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Aug 8, 25 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 22, 25 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jul 15, 25 | Morgan Stanley | UPGRADE | Equal-Weight | Overweight |
| May 29, 25 | Jefferies | INITIATED | — | Hold |
| May 19, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| May 16, 25 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| May 15, 25 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| May 12, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate$2.58 / yr
Forward yield1.22%
5-year avg yield0.91%
Payout ratio30.81%
Ex-dividend dateSep 4, 2026
Next pay dateSep 25, 2026
Last split2:1
Split dateAug 25, 1998
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-08-05
Annual report of employee stock purchase
11-K · 2026-06-16
Proxy Statements
DEF 14A · 2026-06-11
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Periodic Financial Reports
10-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-11
Headlines
3 Healthcare Stocks That Fall Short
StockStory · 9d ago
3 Mid-Cap Stocks with Open Questions
StockStory · 15d ago
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Brush Off
StockStory · 18d ago
STERIS Stock: Is STE Underperforming the Healthcare Sector?
Barchart · 21d ago
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Zacks · 33d ago
STERIS (STE) Stock Looks Reasonable On Earnings With Cash Flow Slightly Stretched
Simply Wall St. · 34d ago
STERIS (STE) Could Be 12% Below Fair Value As Conference Focus Returns
Simply Wall St. · 35d ago
STERIS to Present at the Morgan Stanley Healthcare Conference
GlobeNewswire · 35d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.